$OPCH
Option Care Health, Inc. Stock $opch

$opch Overview Financials Valuation SEC Filings Company Website

2016 Q2 Form 10-Q Financial Statement

#000101473916000024 Filed on May 06, 2016

Income Statement

Concept	2016 Q2	2016 Q1	2015 Q1
Revenue	$232.5M	$238.5M	$244.4M
YoY Change	-5.85%	-2.41%	2.11%
Cost Of Revenue	$168.3M	$174.2M	$179.4M
YoY Change	-7.57%	-2.88%	2.99%
Gross Profit	$63.27M	$63.30M	$64.96M
YoY Change	-2.39%	-2.54%	4.53%
Gross Profit Margin	27.22%	26.55%	26.58%
Selling, General & Admin	$13.70M	$18.60M	$20.00M
YoY Change	-49.26%	-7.0%	-69.6%
% of Gross Profit	21.65%	29.38%	30.79%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$4.300M	$4.538M	$5.794M
YoY Change	4.12%	-21.68%	51.04%
% of Gross Profit	6.8%	7.17%	8.92%
Operating Expenses	$58.60M	$62.80M	$67.50M
YoY Change	-23.4%	-6.96%	3.37%
Operating Profit	$4.666M	-$1.273M	-$6.203M
YoY Change	-101.84%	-79.48%	-44.94%
Interest Expense	-$9.500M	-$9.400M	-$9.200M
YoY Change	4.4%	2.17%	-187.63%
% of Operating Profit	-203.6%
Other Income/Expense, Net
YoY Change
Pretax Income	-$8.770M	-$10.31M	-$15.37M
YoY Change	-96.69%	-32.9%	-34.9%
Income Tax	$149.0K	$23.00K	$1.928M
% Of Pretax Income
Net Earnings	-$8.750M	-$9.830M	-$19.67M
YoY Change	-96.43%	-50.04%	-22.28%
Net Earnings / Revenue	-3.76%	-4.12%	-8.05%
Basic Earnings Per Share
Diluted Earnings Per Share	-$448.1K	-$552.3K	-$1.145M
COMMON SHARES
Basic Shares Outstanding	68.78M shares	68.77M shares	68.64M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2016 Q2	2016 Q1	2015 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$51.40M	$8.100M	$23.20M
YoY Change	4183.33%	-65.09%	149.46%
Cash & Equivalents	$51.43M	$8.049M	$23.25M
Short-Term Investments
Other Short-Term Assets	$16.50M	$19.90M	$10.60M
YoY Change	58.65%	87.74%	-13.82%
Inventory	$32.45M	$29.12M	$41.88M
Prepaid Expenses
Receivables	$98.60M	$101.8M	$136.7M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$199.0M	$158.8M	$212.4M
YoY Change	7.34%	-25.2%	-15.51%
LONG-TERM ASSETS
Property, Plant & Equipment	$30.79M	$30.48M	$35.93M
YoY Change	-11.79%	-15.16%	-10.06%
Goodwill	$308.7M	$308.7M	$573.3M
YoY Change	-7.93%	-46.15%	0.26%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$1.203M	$1.130M	$1.247M
YoY Change	0.92%	-9.38%	-65.13%
Total Long-Term Assets	$344.2M	$344.6M	$633.1M
YoY Change	-12.13%	-45.56%	-2.41%
TOTAL ASSETS
Total Short-Term Assets	$199.0M	$158.8M	$212.4M
Total Long-Term Assets	$344.2M	$344.6M	$633.1M
Total Assets	$543.2M	$503.5M	$845.4M
YoY Change	-5.87%	-40.44%	-6.07%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$48.89M	$53.08M	$91.11M
YoY Change	-36.58%	-41.74%	33.42%
Accrued Expenses	$39.90M	$46.60M	$43.70M
YoY Change	-16.18%	6.64%	-2.89%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$9.400M	$32.20M	$300.0K
YoY Change	4600.0%	10633.33%	-25.0%
Total Short-Term Liabilities	$101.7M	$135.7M	$145.2M
YoY Change	-24.15%	-6.52%	13.79%
LONG-TERM LIABILITIES
Long-Term Debt	$390.1M	$391.7M	$418.5M
YoY Change	-6.81%	-6.4%	0.07%
Other Long-Term Liabilities	$1.655M	$2.099M	$2.656M
YoY Change	-75.98%	-20.97%	-70.29%
Total Long-Term Liabilities	$1.655M	$2.099M	$2.656M
YoY Change	-75.98%	-20.97%	-70.29%
TOTAL LIABILITIES
Total Short-Term Liabilities	$101.7M	$135.7M	$145.2M
Total Long-Term Liabilities	$1.655M	$2.099M	$2.656M
Total Liabilities	$494.0M	$529.9M	$587.2M
YoY Change	-12.17%	-9.75%	3.49%
SHAREHOLDERS EQUITY
Retained Earnings	-$619.7M	-$611.4M	-$321.9M
YoY Change	9.35%	89.96%	78.77%
Common Stock	$612.6M	$530.7M	$536.8M
YoY Change	14.7%	-1.14%	2.64%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$11.01M	$10.75M	$10.72M
YoY Change	2.74%	0.36%	3.92%
Treasury Stock Shares	2.761M shares	2.661M shares	2.645M shares
Shareholders Equity	-$18.08M	-$91.52M	$204.2M
YoY Change
Total Liabilities & Shareholders Equity	$543.2M	$503.5M	$845.4M
YoY Change	-5.87%	-40.44%	-6.07%

Cashflow Statement

Concept	2016 Q2	2016 Q1	2015 Q1
OPERATING ACTIVITIES
Net Income	-$8.750M	-$9.830M	-$19.67M
YoY Change	-96.43%	-50.04%	-22.28%
Depreciation, Depletion And Amortization	$4.300M	$4.538M	$5.794M
YoY Change	4.12%	-21.68%	51.04%
Cash From Operating Activities	-$10.60M	-$10.96M	-$28.05M
YoY Change	-41.76%	-60.91%	7.93%
INVESTING ACTIVITIES
Capital Expenditures	-$3.100M	$2.429M	-$2.100M
YoY Change	-16.22%	-215.67%	-32.26%
Acquisitions
YoY Change
Other Investing Activities	$0.00	$1.100M	$0.00
YoY Change			-100.0%
Cash From Investing Activities	-$3.000M	-$1.324M	-$2.066M
YoY Change	-18.92%	-35.91%	-103.86%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		$0.00
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	57.00M	$4.759M	$52.62M
YoY Change	-28600.0%	-90.96%	-372.38%
NET CHANGE
Cash From Operating Activities	-10.60M	-$10.96M	-$28.05M
Cash From Investing Activities	-3.000M	-$1.324M	-$2.066M
Cash From Financing Activities	57.00M	$4.759M	$52.62M
Net Change In Cash	43.40M	-$7.528M	$22.51M
YoY Change	-296.38%	-133.45%	172.73%
FREE CASH FLOW
Cash From Operating Activities	-$10.60M	-$10.96M	-$28.05M
Capital Expenditures	-$3.100M	$2.429M	-$2.100M
Free Cash Flow	-$7.500M	-$13.39M	-$25.95M
YoY Change	-48.28%	-48.39%	13.37%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2015Q4	bios	Accrued Expenses And Other Current Liabilities AccruedExpensesAndOtherCurrentLiabilities	52918000	USD
CY2016Q1	bios	Accrued Expenses And Other Current Liabilities AccruedExpensesAndOtherCurrentLiabilities	44329000	USD
CY2015Q1	bios	Acquisition Integration Restructuringand Other Expenses AcquisitionIntegrationRestructuringandOtherExpenses	3704000	USD
CY2016Q1	bios	Acquisition Integration Restructuringand Other Expenses AcquisitionIntegrationRestructuringandOtherExpenses	2667000	USD
CY2015Q4	bios	Amounts Due To Plan Sponsors AmountsDueToPlanSponsors	3491000	USD
CY2016Q1	bios	Amounts Due To Plan Sponsors AmountsDueToPlanSponsors	3812000	USD
CY2016Q1	bios	Classof Warrantor Right Exercise Priceof Warrantsor Rights Percentageof Market Price ClassofWarrantorRightExercisePriceofWarrantsorRightsPercentageofMarketPrice	0.85
CY2016Q1	bios	Debt Instrument Debt Default Interest Rate Penalty Increase DebtInstrumentDebtDefaultInterestRatePenaltyIncrease	0.02
CY2015Q1	bios	Gain Losson Changein Fair Valueof Contingent Consideration GainLossonChangeinFairValueofContingentConsideration	-21000	USD
CY2016Q1	bios	Gain Losson Changein Fair Valueof Contingent Consideration GainLossonChangeinFairValueofContingentConsideration	-51000	USD
CY2015Q1	bios	Increase Decreasein Amounts Due To Plan Sponsor IncreaseDecreaseinAmountsDueToPlanSponsor	-1511000	USD
CY2016Q1	bios	Increase Decreasein Amounts Due To Plan Sponsor IncreaseDecreaseinAmountsDueToPlanSponsor	321000	USD
CY2015Q1	bios	Increase Decreasein Fair Valueof Contingent Consideration IncreaseDecreaseinFairValueofContingentConsideration	-21000	USD
CY2016Q1	bios	Increase Decreasein Fair Valueof Contingent Consideration IncreaseDecreaseinFairValueofContingentConsideration	-51000	USD
CY2015Q4	bios	Long Term Debt And Capital Lease Obligations Total LongTermDebtAndCapitalLeaseObligationsTotal	418121000	USD
CY2015Q1	bios	Proceedsfrom Issuanceof Equityand Temporary Equity ProceedsfromIssuanceofEquityandTemporaryEquity	62500000	USD
CY2016Q1	bios	Proceedsfrom Issuanceof Convertible Preferred Stockand Warrants ProceedsfromIssuanceofConvertiblePreferredStockandWarrants	0	USD
CY2016Q1	bios	Long Term Debt And Capital Lease Obligations Total LongTermDebtAndCapitalLeaseObligationsTotal	423930000	USD
CY2016Q1	bios	Maximum Net Leverage Ratio Is Consistent With Prior Quarters Number MaximumNetLeverageRatioIsConsistentWithPriorQuartersNumber	4	Quarters
CY2015Q1	bios	Proceedsfrom Issuanceof Convertible Preferred Stockand Warrants ProceedsfromIssuanceofConvertiblePreferredStockandWarrants	58951000	USD
CY2016Q1	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2016Q1	dei	Entity Registrant Name EntityRegistrantName	BioScrip, Inc.
CY2015Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	65077000	USD
CY2016Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	53082000	USD
CY2016Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	68780241	shares
CY2016Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	17500000	shares
CY2015Q4	us-gaap	Assets Assets	530642000	USD
CY2015Q1	bios	Proceedsfrom Issuanceof Equityand Temporary Equity ProceedsfromIssuanceofEquityandTemporaryEquity	62500000	USD
CY2015Q3	bios	Proceedsfrom Issuanceof Equityand Temporary Equity ProceedsfromIssuanceofEquityandTemporaryEquity	1100000	USD
CY2015Q1	bios	Proceedsfrom Issuanceof Temporary Equity ProceedsfromIssuanceofTemporaryEquity	59355000	USD
CY2016Q1	bios	Repayments Of Debt Including Accrued Interest RepaymentsOfDebtIncludingAccruedInterest	45300000	USD
CY2015Q1	bios	Stock Purchase Agreement Covenant Terms Minimum Percentageof Proceedstobe Usedon Repaymentof Debt StockPurchaseAgreementCovenantTermsMinimumPercentageofProceedstobeUsedonRepaymentofDebt	0.75
CY2016Q1	bios	Stock Purchase Agreement Percentageof Proceeds Usedto Repayof Debt StockPurchaseAgreementPercentageofProceedsUsedtoRepayofDebt	0.77
CY2016Q1	dei	Amendment Flag AmendmentFlag	false
CY2016Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2016Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2016Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2016
CY2016Q1	dei	Document Period End Date DocumentPeriodEndDate	2016-03-31
CY2016Q1	dei	Document Type DocumentType	10-Q
CY2016Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001014739
CY2015Q4	us-gaap	Accounts Receivable Gross AccountsReceivableGross	157042000	USD
CY2016Q1	us-gaap	Accounts Receivable Gross AccountsReceivableGross	158575000	USD
CY2015Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	97353000	USD
CY2016Q1	us-gaap	Accounts Receivable Net AccountsReceivableNet	101770000	USD
CY2015Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	531764000	USD
CY2016Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	530671000	USD
CY2015Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	59689000	USD
CY2016Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	56805000	USD
CY2015Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	59689000	USD
CY2016Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	56805000	USD
CY2015Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	780000	USD
CY2016Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	1003000	USD
CY2015Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	5794000	USD
CY2016Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	4538000	USD
CY2015Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	10800000	shares
CY2016Q1	us-gaap	Assets Assets	503494000	USD
CY2015Q4	us-gaap	Assets Current AssetsCurrent	183685000	USD
CY2016Q1	us-gaap	Assets Current AssetsCurrent	158845000	USD
CY2015Q1	us-gaap	Business Combination Integration Related Costs BusinessCombinationIntegrationRelatedCosts	220000	USD
CY2016Q1	us-gaap	Business Combination Integration Related Costs BusinessCombinationIntegrationRelatedCosts	362000	USD
CY2014Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	740000	USD
CY2015Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	23246000	USD
CY2015Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	15577000	USD
CY2016Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	8051000	USD
CY2015Q1	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	22506000	USD
CY2016Q1	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-7526000	USD
CY2015Q4	us-gaap	Common Stock Value CommonStockValue	8000	USD
CY2016Q1	us-gaap	Common Stock Value CommonStockValue	8000	USD
CY2015Q1	us-gaap	Cost Of Revenue CostOfRevenue	179402000	USD
CY2016Q1	us-gaap	Cost Of Revenue CostOfRevenue	174230000	USD
CY2016Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	4306000	USD
CY2015Q1	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	0	USD
CY2015Q1	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	-1421000	USD
CY2016Q1	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	-5989000	USD
CY2015Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2016Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2015Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	125000000	shares
CY2016Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	125000000	shares
CY2015Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	71421664	shares
CY2016Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	71441664	shares
CY2015Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	68767613	shares
CY2016Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	68780241	shares
CY2015Q1	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	USD
CY2016Q1	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	USD
CY2015Q1	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	1000	USD
CY2016Q1	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	0	USD
CY2015Q1	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	1000	USD
CY2016Q1	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	0	USD
CY2015Q1	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	1628000	USD
CY2016Q1	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	17000	USD
CY2015Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	15863000	USD
CY2016Q1	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	15018000	USD
CY2015Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	1927000	USD
CY2016Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	23000	USD
CY2015Q1	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	299000	USD
CY2016Q1	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	6000	USD
CY2015Q4	us-gaap	Deferred Tax Liabilities Gross Noncurrent DeferredTaxLiabilitiesGrossNoncurrent	236000	USD
CY2016Q1	us-gaap	Deferred Tax Liabilities Gross Noncurrent DeferredTaxLiabilitiesGrossNoncurrent	410000	USD
CY2015Q1	us-gaap	Depreciation Depreciation	5794000	USD
CY2016Q1	us-gaap	Depreciation Depreciation	4538000	USD
CY2015Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.31
CY2016Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.17
CY2015Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	5128000	USD
CY2016Q1	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	939000	USD
CY2015Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2016Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	939000	USD
CY2015Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	11699000	USD
CY2016Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	11051000	USD
CY2015Q4	us-gaap	Goodwill Goodwill	308729000	USD
CY2016Q1	us-gaap	Goodwill Goodwill	308729000	USD
CY2015Q1	us-gaap	Gross Profit GrossProfit	64955000	USD
CY2016Q1	us-gaap	Gross Profit GrossProfit	64232000	USD
CY2015Q1	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	-2379000	USD
CY2016Q1	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	233000	USD
CY2015Q1	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	-4585000	USD
CY2015Q1	us-gaap	Health Care Organization Revenue HealthCareOrganizationRevenue	244357000	USD
CY2016Q1	us-gaap	Health Care Organization Revenue HealthCareOrganizationRevenue	238462000	USD
CY2015Q1	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-17294000	USD
CY2016Q1	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-9769000	USD
CY2015Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-15366000	USD
CY2016Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-9746000	USD
CY2015Q1	us-gaap	Income Loss From Continuing Operations Per Basic And Diluted Share IncomeLossFromContinuingOperationsPerBasicAndDilutedShare	-0.28
CY2016Q1	us-gaap	Income Loss From Continuing Operations Per Basic And Diluted Share IncomeLossFromContinuingOperationsPerBasicAndDilutedShare	-0.17
CY2015Q1	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic And Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare	-0.03
CY2016Q1	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic And Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare	0.00
CY2015Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1928000	USD
CY2016Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	23000	USD
CY2015Q1	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	6781000	USD
CY2016Q1	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	3388000	USD
CY2015Q1	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-4892000	USD
CY2016Q1	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-3411000	USD
CY2015Q1	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	39000	USD
CY2016Q1	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	62000	USD
CY2015Q1	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	0	USD
CY2016Q1	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-16000	USD
CY2015Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	528000	USD
CY2016Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	13000	USD
CY2015Q1	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	995000	USD
CY2016Q1	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-11995000	USD
CY2015Q1	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	-1927000	USD
CY2016Q1	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	-174000	USD
CY2016Q1	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	-4630000	USD
CY2015Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	4666000	USD
CY2016Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-13867000	USD
CY2015Q1	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	-9689000	USD
CY2016Q1	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	-2548000	USD
CY2015Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	854000	USD
CY2016Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-7897000	USD
CY2015Q1	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	-799000	USD
CY2016Q1	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	4417000	USD
CY2015Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-9163000	USD
CY2016Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-9412000	USD
CY2015Q1	us-gaap	Interest Paid Net InterestPaidNet	13748000	USD
CY2016Q1	us-gaap	Interest Paid Net InterestPaidNet	13143000	USD
CY2015Q4	us-gaap	Interest Payable Current InterestPayableCurrent	6898000	USD
CY2016Q1	us-gaap	Interest Payable Current InterestPayableCurrent	2268000	USD
CY2015Q4	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	393741000	USD
CY2016Q1	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	391729000	USD
CY2015Q4	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	24380000	USD
CY2016Q1	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	32201000	USD
CY2016Q1	us-gaap	Loss Contingency Accrual At Carrying Value LossContingencyAccrualAtCarryingValue	15000000	USD
CY2016Q1	us-gaap	Loss Contingency Accrual At Carrying Value LossContingencyAccrualAtCarryingValue	15000000	USD
CY2016Q1	us-gaap	Net Income Loss NetIncomeLoss	-9536000	USD
CY2015Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-21290000	USD
CY2016Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-11706000	USD
CY2015Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-6203000	USD
CY2016Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-1273000	USD
CY2015Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1161000	USD
CY2016Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1130000	USD
CY2015Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1861000	USD
CY2015Q4	us-gaap	Inventory Net InventoryNet	42983000	USD
CY2016Q1	us-gaap	Inventory Net InventoryNet	29116000	USD
CY2015Q4	us-gaap	Liabilities Liabilities	548602000	USD
CY2016Q1	us-gaap	Liabilities Liabilities	529930000	USD
CY2015Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	530642000	USD
CY2016Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	503494000	USD
CY2015Q4	us-gaap	Liabilities Current LiabilitiesCurrent	152764000	USD
CY2016Q1	us-gaap	Liabilities Current LiabilitiesCurrent	135692000	USD
CY2016Q1	us-gaap	Long Term Debt LongTermDebt	415811000	USD
CY2015Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	52619000	USD
CY2016Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	4759000	USD
CY2015Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2066000	USD
CY2016Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1323000	USD
CY2015Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-28047000	USD
CY2016Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-10962000	USD
CY2015Q1	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-26626000	USD
CY2016Q1	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-4973000	USD
CY2015Q1	us-gaap	Net Income Loss NetIncomeLoss	-19673000	USD
CY2016Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	2099000	USD
CY2015Q1	us-gaap	Other Selling General And Administrative Expense OtherSellingGeneralAndAdministrativeExpense	41615000	USD
CY2016Q1	us-gaap	Other Selling General And Administrative Expense OtherSellingGeneralAndAdministrativeExpense	39658000	USD
CY2015Q1	us-gaap	Payments For Proceeds From Productive Assets PaymentsForProceedsFromProductiveAssets	2066000	USD
CY2016Q1	us-gaap	Payments For Proceeds From Productive Assets PaymentsForProceedsFromProductiveAssets	2429000	USD
CY2015Q1	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	1218000	USD
CY2016Q1	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	0	USD
CY2015Q1	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	4000000	USD
CY2015Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2016Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2015Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	4175000	shares
CY2016Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	4175000	shares
CY2015Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2016Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2016Q1	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	1106000	USD
CY2015Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	62918000	USD
CY2015Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2016Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2015Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2016Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2015Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	27772000	USD
CY2016Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	19908000	USD
CY2015Q3	us-gaap	Proceeds From Divestiture Of Businesses Net Of Cash Divested ProceedsFromDivestitureOfBusinessesNetOfCashDivested	24600000	USD
CY2015Q1	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	3145000	USD
CY2015Q1	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	74963000	USD
CY2016Q1	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	21000000	USD
CY2015Q1	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	0	USD
CY2016Q1	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-53000	USD
CY2015Q1	us-gaap	Proceeds From Repayments Of Secured Debt ProceedsFromRepaymentsOfSecuredDebt	0	USD
CY2016Q1	us-gaap	Proceeds From Repayments Of Secured Debt ProceedsFromRepaymentsOfSecuredDebt	-3137000	USD
CY2015Q1	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	0	USD
CY2015Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	31939000	USD
CY2016Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	30484000	USD
CY2015Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	8346000	USD
CY2016Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	7591000	USD
CY2015Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	97353000	USD
CY2016Q1	us-gaap	Receivables Net Current ReceivablesNetCurrent	101770000	USD
CY2015Q1	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	114000	USD
CY2016Q1	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	51000	USD
CY2015Q1	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	79963000	USD
CY2016Q1	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	13000000	USD
CY2015Q1	us-gaap	Restructuring Charges RestructuringCharges	3463000	USD
CY2016Q1	us-gaap	Restructuring Charges RestructuringCharges	2254000	USD
CY2015Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-601913000	USD
CY2016Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-611449000	USD
CY2015Q1	us-gaap	Share Based Compensation ShareBasedCompensation	1657000	USD
CY2016Q1	us-gaap	Share Based Compensation ShareBasedCompensation	1474000	USD
CY2015Q4	us-gaap	Stockholders Equity StockholdersEquity	-80878000	USD
CY2016Q1	us-gaap	Stockholders Equity StockholdersEquity	-91524000	USD
CY2015Q1	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	1164000	USD
CY2016Q1	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	172000	USD
CY2016Q1	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	65088000	USD
CY2015Q1	us-gaap	Temporary Equity Dividends Adjustment TemporaryEquityDividendsAdjustment	453000	USD
CY2016Q1	us-gaap	Temporary Equity Dividends Adjustment TemporaryEquityDividendsAdjustment	1998000	USD
CY2015Q4	us-gaap	Temporary Equity Liquidation Preference TemporaryEquityLiquidationPreference	69702000	USD
CY2016Q1	us-gaap	Temporary Equity Liquidation Preference TemporaryEquityLiquidationPreference	71701000	USD
CY2015Q4	us-gaap	Temporary Equity Par Or Stated Value Per Share TemporaryEquityParOrStatedValuePerShare	0.0001
CY2016Q1	us-gaap	Temporary Equity Par Or Stated Value Per Share TemporaryEquityParOrStatedValuePerShare	0.0001
CY2015Q4	us-gaap	Temporary Equity Shares Authorized TemporaryEquitySharesAuthorized	825000	shares
CY2016Q1	us-gaap	Temporary Equity Shares Authorized TemporaryEquitySharesAuthorized	825000	shares
CY2015Q4	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	635822	shares
CY2016Q1	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	635822	shares
CY2015Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	635822	shares
CY2016Q1	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	635822	shares
CY2015Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	2654051	shares
CY2016Q1	us-gaap	Treasury Stock Shares TreasuryStockShares	2661423	shares
CY2015Q4	us-gaap	Treasury Stock Value TreasuryStockValue	10737000	USD
CY2016Q1	us-gaap	Treasury Stock Value TreasuryStockValue	10754000	USD
CY2015Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	68637000	shares
CY2016Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	68771000	shares

Files In Submission

Name	View Source	Status
0001014739-16-000024-index-headers.html	Edgar Link	pending
0001014739-16-000024-index.html	Edgar Link	pending
0001014739-16-000024.txt	Edgar Link	pending
0001014739-16-000024-xbrl.zip	Edgar Link	pending
bios-20160331.xml	Edgar Link	completed
bios-20160331.xsd	Edgar Link	pending
bios-20160331x10q.htm	Edgar Link	pending
bios-20160331_cal.xml	Edgar Link	unprocessable
bios-20160331_def.xml	Edgar Link	unprocessable
bios-20160331_lab.xml	Edgar Link	unprocessable
bios-20160331_pre.xml	Edgar Link	unprocessable
bios-ex311x2016033110xq.htm	Edgar Link	pending
bios-ex312x2016033110xq.htm	Edgar Link	pending
bios-ex321x2016033110xq.htm	Edgar Link	pending
bios-ex322x2016033110xq.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
logowithregisteredtm03.jpg	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$OPCH
Option Care Health, Inc. Stock $opch

2016 Q2 Form 10-Q Financial Statement

#000101473916000024 Filed on May 06, 2016

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$OPCH Option Care Health, Inc. Stock $opch

2016 Q2 Form 10-Q Financial Statement

#000101473916000024 Filed on May 06, 2016

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$OPCH
Option Care Health, Inc. Stock $opch